BCAT1 and Alzheimer disease: Blood levels of BCAAs are elevated in the blood of humans with Alzheimer’s disease (AD) and mouse models of the disease, and brain BCAA catabolism is impaired in the brains of models of AD by downregulation of Bcat1 expression (Li, Ye et al., 2018).